Contact Us
Schwab Client Login
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

283.07 +2.66 (+0.95%)
Delayed Quote Updated: 10:29 AM EST, Nov 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ
From Pomerantz LLP
Via GlobeNewswire
News headline image
Data Show Positive Survival and Patient Outcomes with Best-Practice Impella Support in HRPCI, in Contrast to CHIP-BCIS3 Study Results
From Johnson & Johnson
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ
From Pomerantz LLP
Via GlobeNewswire
News headline image
Johnson & Johnson to Host Enterprise Business Review
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Reports First Real-World VARIPULSE Pro Platform Data and 12-Month OMNYPULSE Platform Outcomes for Atrial Fibrillation Treatment at APHRS 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Launches Next-Generation Shockwave™ C2 Aero Fly Coronary IVL Catheter, Cutting IVL Treatment Time in Half
From Johnson & Johnson
Via Business Wire
News headline image
JNJ Investors with $100,000 in Losses Have Opportunity to Join Johnson & Johnson Fraud Investigation with SBS Law
From Schall, Brown & Schwartz LLP
Via Business Wire
News headline image
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson reports Q3 2026 results, raises 2026 guidance
From Johnson & Johnson
Via Business Wire
News headline image
DocMagic’s Lori Johnson named a 2026 Powerful Woman of Mortgage Banking
TORRANCE, Calif., Oct. 8, 2026 (SEND2PRESS NEWSWIRE) -- DocMagic® announced today that Chief Operating Officer Lori Johnson has been named one of Mortgage Banker's 2026 Powerful Women of Mortgage... 
Via Send2Press
News headline image
New Global Survey by Johnson & Johnson Finds Most Women Don’t Connect Eye Health Changes with Menopause
From Johnson & Johnson
Via Business Wire
News headline image
DePuy Synthes Showcases Next-Generation Trauma Innovations at OTA 2026
From DePuy Synthes
Via Business Wire
News headline image
Johnson & Johnson Receives CE Marking for ACUVUE OASYS MAX Reusable Contact Lenses
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
News headline image
A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout
Issued on behalf of Helus Pharma (Nasdaq: HELP) 
From USA News Group
Via GlobeNewswire
News headline image
Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare Conference
From Johnson & Johnson
Via Business Wire
News headline image
Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One
Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU) 
From American News Group
Via GlobeNewswire
News headline image
Johnson & Johnson’s Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System
From Johnson & Johnson
Via Business Wire
News headline image
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates
EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:CMPS),(NASDAQ:ATAI),(NYSE:JNJ),(NYSE:LLY) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
Johnson & Johnson Announces Collaboration with TIME to Introduce New Healthcare Champion of the Year Award
From Johnson & Johnson
Via Business Wire
News headline image
DePuy Synthes Acquires Expanding Innovations™
From DePuy Synthes
Via Business Wire
News headline image
Author’s Tranquility Press Announces a Powerful New Memoir of Faith, Survival, and Purpose
Via AB Newswire
News headline image
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2026
From Johnson & Johnson
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.